Excel Life Sciences Continues Successful Management of Clinical Trials in India as Regulators Work to Improve Review Process

Excel Life Sciences President and Chief Medical Officer, Dr. Vijai Kumar, is featured in a just released story on the evolving clinical research landscape in India. The article which appears in the web-based publication, eCliniqua, discusses some of the ongoing changes underway to create a more robust, efficient and predictable regulatory review process in India for clinical trials. Dr. Kumar shares information on the approach Excel Life Sciences takes to ensure timely regulatory approval for its clients global clinical trials. The company, with a unique operating model involving deployment of its own clinical research coordinators to each site, prides itself on a strong track record and focus on running ethical trials and delivering data quality and data integrity to its clients.

Please click here to read the full article